Page 18 - GP Spring 2022
P. 18

2021 Updates on Antibiotic Prophylaxis


                                      By Marci Levine, DMD, MD and Analia Veitz-Keenan, DDS


        Introduction                          and flossing of their teeth every day.    Such  The  AHA did not recommend  antibiotic
                                                                           5
        Antibiotic prophylaxis (AP) for patients un-  patients need to maintain good oral hygiene  prophylaxis for patients  undergoing he-
        dergoing invasive dental treatments remains  with regular dental  examinations  and pro-  modialysis;  consultation  with  the  treating
        a controversial topic.  Often patients or cli-  fessional cleanings to mitigate these risks.    nephrologist before dental work is recom-
        nicians follow outdated  recommendations,                                  mended to assess the patient’s risk for infec-
        and conflicts arise between dentists and pa-  The indications for the use of prophylaxis in  tion as patients with end-stage renal disease
        tients  when updated,  and  often  unfamiliar  this patient group includes those with pros-  have a higher risk for IE. 11-13
        recommendations are advised to patients.    thetic cardiac valves or materials for valve
                                              repair, a history of IE, a cardiac transplant  Therefore,  obtaining  a thorough medical
        The overuse of antibiotics  is a worldwide  with  structurally  abnormal  valves,  a  cya-  risk assessment is paramount.   Evaluating
        concern because it may result in antibiotic  notic congenital cardiac disease that is un-  any prior history of IE, medical conditions
        resistance.  Several organizations, including  repaired, or disease that is repaired but has  such as uncontrolled diabetes, immunodefi-
        the Centers for Disease Control and Preven-  residual shunts or regurgitation.    ciency, chronic steroid use, or neutropenia
                                                                       5-7
        tion, advocate  the use of antibiotics  with                               secondary to chemotherapy are highly rel-
        caution and favor their use to be reserved  The first six months after cardiac transplan-  evant to dental care and these risk factors
        for situations in which antibiotics are neces-  tation is associated with an increased risk of  may make patients more susceptible to in-
                                                1
        sary and essential.                   IE.  At-risk patients should be managed in  fections.
                       1
                                              consultation  with their  treating  cardiology
        The purpose of this review is to outline the  team and recommendations for prophylax-  Some dentists in practice may also encoun-
        most  current  recommendations  for antibi-  is should be mutually  agreed upon before  ter pediatric patients with congenital cardiac
        otic prophylaxis and to update the reader  treatment.                      diseases who require antibiotic prophylaxis.
        on the appropriate management of the use                                   The categories for which conditions in chil-
        of prophylactic  antibiotics  in some com-  Miscellaneous Conditions/Non-Valvular   dren warrant prophylaxis have not changed
        monly seen scenarios encountered in clin-  Considerations                  from prior recommendations. These include
        ical  practice,  such as patients  who have  Some patients who have non-valvular con-  unrepaired cyanotic congenital disease, re-
        had joint replacements, those with cardiac  siderations such as a history of heart failure  paired disease within the first six months of
        or non-valvular diseases, and patients who  may require the installation of left ventric-  surgery, and repaired disease with residual
        need antibiotic premedication but are aller-  ular assist devices  (LVADs). Given that  defects, leaks, or abnormal flow.  It is im-
        gic to amoxicillin.                   LVADs  and implantable  heart devices are  portant  to remember  that  children  should
                                              more commonly used now, dentists should  receive  antibiotic  dosages based on their
        The American  Heart Association  (AHA)  be prepared to adequately manage these pa-  body weight (unlike adults) and should be
        guidelines for the use of antibiotic prophy-  tients’ needs in the ambulatory setting.  The  checked for the presence of allergies or hy-
        laxis to prevent infective endocarditis (IE)  literature well supports the use of antibiotic  persensitivity  reactions  as  some  children
        before dental  treatment  were updated in  prophylaxis for patients with LVADs.  It is  may be antibiotic naive.
        May 2021.  Compared to prior guidelines ,  reasonable given the significant risk of in-
                                          3
                 2
        a revised group of patients now qualifies to  fection in the face of a compromised cardio-  As a dentist, it is essential to work with a
        receive antibiotic prophylaxis. As we now  vascular system.                patient’s treating physicians to help balance
                                                           1
        know, the  risks related  to complications                                 potential risks and benefits, especially when
        secondary to antibiotic  use may outweigh  There  are  situations  where  an  individual  the indications for antibiotic  prophylaxis
        the benefits of prophylaxis for patients that  may have a cardiac condition or an implant  may be unclear. When using such a collab-
        were  previously  covered.    The  definition  of some sort that does not require antibiot-  orative approach, it has been our experience
        of invasive  dental  treatments  is  critical  to  ic prophylaxis.  Patients with cardiovascu-  that  patients  respond favorably  when the
        consider procedures in which the gingival  lar  pacemakers, implantable  cardioverter  providers are all working together in the pa-
        tissues and/or oral  mucosa  are penetrated,  stimulators, stents, shunts, filters, and septal  tient’s best interest.
        increasing the risk of bacteremia. 2,3  defects closure where complete closure has
                                              been obtained, do not require antibiotic pro-  In summary, the following cardiac condi-
        Prevention of IE in Cardiac Conditions  phylaxis.                          tions require the use of antibiotic prophy-
        Most of the indications for antibiotic pro-                                laxis before invasive dental procedures  :
                                                                                                                    7
        phylaxis for the prevention of IE from car-  Other situations, such as patients who have
        diac conditions listed by both the ADA and  breast implants   as well as different types of  ●  Prosthetic cardiac valve or other valve
                                                          8
        AHA (American Heart Association) remain  implants 9,10   such as penile implants, do not   material
        unchanged from 2007 with some additions  require antibiotic prophylaxis before dental   ●  Cardiac valve repaired with devices,
        and modifications.                    treatment unless their medical condition(s)   including annuloplasty, rings, or clips
                       4
                                              or medical histories warrant its use.
        However, debate exists as to the timing of                                 ●  Transcatheter implantation of prosthet-
        prophylaxis.  Patients at the highest risk for  The dentist should discuss with the patient’s   ic valves
        IE should continue  to receive  prophylaxis  physician(s) the need for antibiotic prophy-  ●  Previous, relapse, or recurrent infec-
        despite  the  concomitant  risks of drug-to-  laxis for immunocompromised  patients or   tious endocarditis
        drug interactions and drug resistance.  These  patients with central venous access, depen-
        patients  are  also  susceptible  to transient  dent upon the dental procedures needed for   ●  Unrepaired congenital  heart disease
        bacteremia and IE during routine brushing  the patient.                        (CHD), including palliative shunts and
                                                                                       conduits
        www.nysagd.org l Spring 2022 l GP 18
   13   14   15   16   17   18   19   20   21   22   23